Literature DB >> 30630104

HBV Genotype-Specific Levels of Hepatitis B Surface Antigen Improve HBV Phenotype Definition.

Willem P Brouwer1, Qian Zhao2, Bettina E Hansen3, Daryl Lau4, Mandana Khalili5, Norah A Terrault5, Adrian M Di Bisceglie6, Robert P Perrillo7, Michael W Fried8, David Wong9, Jordan J Feld9, Steven H Belle2, Harry L A Janssen10.   

Abstract

Controversies exist regarding the classification of the different clinical phases of chronic hepatitis B (CHB) because hepatitis B virus (HBV) DNA and alanine aminotransferase levels fluctuate over time.1,2 To improve the distinction of clinical phases and the associated spectrum of clinical outcome,3,4 hepatitis B surface antigen (HBsAg) levels may be of help.5-7 We hypothesize that HBV genotype specific HBsAg levels are needed for the identification of different clinical HBV disease phases.7.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30630104      PMCID： PMC6612468          DOI： 10.1016/j.cgh.2018.12.039

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


  8 in total

1.  Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels.

Authors:  Teresa Pollicino; Giuliana Amaddeo; Agnese Restuccia; Giuseppina Raffa; Angela Alibrandi; Giuseppina Cutroneo; Angelo Favaloro; Sergio Maimone; Giovanni Squadrito; Giovanni Raimondo
Journal:  Hepatology       Date:  2012-07-13       Impact factor: 17.425

2.  Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia.

Authors:  Tin Nguyen; Alexander J V Thompson; Scott Bowden; Catherine Croagh; Sally Bell; Paul V Desmond; Miriam Levy; Stephen A Locarnini
Journal:  J Hepatol       Date:  2010-02-16       Impact factor: 25.083

3.  Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up.

Authors:  Willem P Brouwer; Henry Lik-Yuen Chan; Maurizia R Brunetto; Michelle Martinot-Peignoux; Pauline Arends; Markus Cornberg; Beatrice Cherubini; Alex J V Thompson; Yun-Fan Liaw; Patrick Marcellin; Harry L A Janssen; Bettina E Hansen
Journal:  Clin Gastroenterol Hepatol       Date:  2016-02-10       Impact factor: 11.382

4.  Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.

Authors:  Jerzy Jaroszewicz; Beatriz Calle Serrano; Karsten Wursthorn; Katja Deterding; Jerome Schlue; Regina Raupach; Robert Flisiak; C-Thomas Bock; Michael P Manns; Heiner Wedemeyer; Markus Cornberg
Journal:  J Hepatol       Date:  2010-02-13       Impact factor: 25.083

5.  Determination of hepatitis B phenotype using biochemical and serological markers.

Authors:  A M Di Bisceglie; M Lombardero; J Teckman; L Roberts; H L A Janssen; S H Belle; J H Hoofnagle
Journal:  J Viral Hepat       Date:  2016-12-05       Impact factor: 3.728

6.  High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.

Authors:  Tai-Chung Tseng; Chun-Jen Liu; Hung-Chih Yang; Tung-Hung Su; Chia-Chi Wang; Chi-Ling Chen; Stephanie Fang-Tzu Kuo; Chen-Hua Liu; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Gastroenterology       Date:  2012-02-11       Impact factor: 22.682

7.  AASLD guidelines for treatment of chronic hepatitis B.

Authors:  Norah A Terrault; Natalie H Bzowej; Kyong-Mi Chang; Jessica P Hwang; Maureen M Jonas; M Hassan Murad
Journal:  Hepatology       Date:  2015-11-13       Impact factor: 17.425

8.  Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.

Authors:  Tai-Chung Tseng; Chun-Jen Liu; Hung-Chih Yang; Tung-Hung Su; Chia-Chi Wang; Chi-Ling Chen; Cheng-An Hsu; Stephanie Fang-Tzu Kuo; Chen-Hua Liu; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Hepatology       Date:  2012-12-06       Impact factor: 17.425
  8 in total
  1 in total

1.  Chemiluminescent Optical Fiber Immunosensor Combining Surface Modification and Signal Amplification for Ultrasensitive Determination of Hepatitis B Antigen.

Authors:  Xuexue Xu; Rongbin Nie; Jingwen Huang; Li Yang
Journal:  Sensors (Basel)       Date:  2020-08-31       Impact factor: 3.576
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.